CL2009001874A1 - Uso de bacillus subtilis qst713 nrrl b-21661 para formular una composición probiótica para un animal; y composición probiotica de bacillus subtilis qst713 nrrl b-21661. - Google Patents

Uso de bacillus subtilis qst713 nrrl b-21661 para formular una composición probiótica para un animal; y composición probiotica de bacillus subtilis qst713 nrrl b-21661.

Info

Publication number
CL2009001874A1
CL2009001874A1 CL2009001874A CL2009001874A CL2009001874A1 CL 2009001874 A1 CL2009001874 A1 CL 2009001874A1 CL 2009001874 A CL2009001874 A CL 2009001874A CL 2009001874 A CL2009001874 A CL 2009001874A CL 2009001874 A1 CL2009001874 A1 CL 2009001874A1
Authority
CL
Chile
Prior art keywords
nrrl
bacillus subtilis
probiotic composition
subtilis qst713
animal
Prior art date
Application number
CL2009001874A
Other languages
English (en)
Inventor
Joseph Schmidt
Desmond JIMENEZ
Original Assignee
Bayer Cropscience Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42039870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2009001874(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Cropscience Lp filed Critical Bayer Cropscience Lp
Publication of CL2009001874A1 publication Critical patent/CL2009001874A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

MÉTODO PARA MEJORAR LA SALUD DE UN ANIMAL QUE COMPRENDE ADMINISTRARLE AL ANIMAL UNA COMPOSICIÓN QUE COMPRENDE BACILLUS SUBTILIS QST 713 O UN MUTANTE DEL MISMO.
CL2009001874A 2008-09-17 2009-09-17 Uso de bacillus subtilis qst713 nrrl b-21661 para formular una composición probiótica para un animal; y composición probiotica de bacillus subtilis qst713 nrrl b-21661. CL2009001874A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19243608P 2008-09-17 2008-09-17

Publications (1)

Publication Number Publication Date
CL2009001874A1 true CL2009001874A1 (es) 2010-04-09

Family

ID=42039870

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001874A CL2009001874A1 (es) 2008-09-17 2009-09-17 Uso de bacillus subtilis qst713 nrrl b-21661 para formular una composición probiótica para un animal; y composición probiotica de bacillus subtilis qst713 nrrl b-21661.

Country Status (23)

Country Link
US (3) US20100092428A1 (es)
EP (2) EP2754354B1 (es)
JP (2) JP6084771B2 (es)
CN (2) CN107047934A (es)
AR (1) AR073606A1 (es)
AU (1) AU2009293213C1 (es)
BR (1) BRPI0918033A8 (es)
CA (1) CA2736885C (es)
CL (1) CL2009001874A1 (es)
CO (1) CO6361864A2 (es)
CR (1) CR20110206A (es)
DK (2) DK2754354T3 (es)
EC (1) ECSP11010975A (es)
ES (2) ES2527673T3 (es)
MX (1) MX2011002889A (es)
NZ (1) NZ592154A (es)
PE (1) PE20120074A1 (es)
PH (1) PH12015501581A1 (es)
PL (1) PL2348880T3 (es)
RU (1) RU2544952C2 (es)
TW (1) TWI574628B (es)
WO (1) WO2010033714A1 (es)
ZA (1) ZA201102627B (es)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2736885C (en) 2008-09-17 2016-12-06 Agraquest, Inc. Method for using a bacillus subtilis strain to enhance animal health
MY161197A (en) * 2010-03-17 2017-04-14 Agraquest Inc Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions
WO2012009712A2 (en) * 2010-07-16 2012-01-19 The Board Of Trustees Of The University Of Arkansas Methods and compositions including spore-forming bacteria for increasing the health of animals
US9107938B2 (en) 2010-09-30 2015-08-18 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
EP2713729A2 (en) 2011-05-24 2014-04-09 Bayer CropScience LP Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
PL2748300T3 (pl) * 2011-08-24 2019-05-31 Dupont Nutrition Biosci Aps Szczepy Bacillus wytwarzające enzym
CN102273428B (zh) * 2011-09-14 2013-01-02 定边县华威生物科技有限公司 一种红蛋黄高蛋白富硒营养鸡蛋生产方法
KR101317549B1 (ko) * 2011-11-08 2013-10-15 씨제이제일제당 (주) 발효 옥수수글루텐의 제조방법
WO2013110133A1 (en) * 2012-01-27 2013-08-01 Gfs Corporation Aus Pty Ltd. Improved poultry farm practices
WO2013153159A1 (en) 2012-04-13 2013-10-17 Chr. Hansen A/S Antibiotic sensitive bacillus strains having antimicrobial effect against e. coli and clostridium perfringens and having high sporulation capacity
FR2992861B1 (fr) * 2012-07-09 2014-10-17 Probionov Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles
WO2014022572A1 (en) 2012-08-01 2014-02-06 Pacific Vet Group-Usa, Inc. Probiotic for amelioration of coccidiosis vaccine reaction
MX2015002639A (es) * 2012-08-31 2015-06-24 Bayer Cropscience Lp Metodo para aumentar la resistencia al estres abiotico de una planta.
US11883443B2 (en) * 2013-04-09 2024-01-30 Novozymes A/S Compositions and methods for improving the health of aquatic animals
JP6415430B2 (ja) 2013-05-17 2018-10-31 アサヒカルピスウェルネス株式会社 反芻動物の乳房炎の予防または治療剤
CN103555707A (zh) * 2013-10-28 2014-02-05 青岛蔚蓝生物集团有限公司 一种制备复合菌剂的方法
JP6440463B2 (ja) * 2013-11-15 2018-12-19 プリマハム株式会社 抗菌作用を有するバチルス・メチロトロフィカス
TWI702004B (zh) 2014-05-13 2020-08-21 美商微生物發現公司 直接餵飼之微生物及其使用方法
WO2016019017A1 (en) * 2014-07-29 2016-02-04 BiOWiSH Technologies, Inc. Animal feed compositions and feed additives
WO2016060935A2 (en) 2014-10-08 2016-04-21 Novozymes A/S Compositions and methods of improving the digestibility of animal feed
US20170246222A1 (en) 2014-10-08 2017-08-31 Novozymes A/S Bacillus Strains with Fast Germination and Antimicrobial Activity against Clostridium
TWI659696B (zh) * 2014-12-12 2019-05-21 南京莎菲特生物科技有限公司 一種製備含高濃度表面素之飼料添加劑的方法
WO2016118840A1 (en) * 2015-01-23 2016-07-28 Novozymes A/S Bacillus strains improving health and performance of production animals
EP3261653B1 (en) 2015-01-23 2019-10-09 Novozymes A/S Bacillus subtilis subspecies
WO2016118864A1 (en) * 2015-01-23 2016-07-28 Novozymes A/S Bacillus strains improving health and performance of production animals
SI3264915T1 (sl) * 2015-03-06 2021-10-29 Norman J Smallwood Sestav krme, ki vsebuje zemeljsko belilo izrabljeno pri obdelavi jedilnega olja
US10632157B2 (en) 2016-04-15 2020-04-28 Ascus Biosciences, Inc. Microbial compositions and methods of use for improving fowl production
US10201574B1 (en) 2015-09-16 2019-02-12 Church & Dwight Co., Inc. Methods of microbial treatment of poultry
WO2017066777A1 (en) * 2015-10-15 2017-04-20 Kemin Industries, Inc. Compositions and methods of improving performance and intestinal health of poultry
CN108603161B (zh) * 2015-11-09 2021-11-09 中国科学院遗传与发育生物学研究所 具有有益活性的芽孢杆菌菌株及制剂
BR112018015148A2 (pt) 2016-01-25 2018-12-18 Novozymes A/S método para melhorar um ou mais parâmetros de desempenho de aves, e, composição
CA3016203A1 (en) 2016-02-29 2017-09-08 Microbial Discovery Group, Llc Direct-fed microbials
US10617134B2 (en) 2016-04-15 2020-04-14 Ascus Biosciences, Inc. Methods for improving agricultural production of fowl by administration of microbial compositions or purified strains thereof
US11298383B2 (en) 2016-05-20 2022-04-12 Church & Dwight Co., Inc. Lactobacillus and bacillus based direct fed microbial treatment for poultry and method of use
BR112018074133A2 (pt) 2016-05-25 2019-03-06 Church & Dwight Co., Inc. composições de bacillus e métodos de uso com ruminantes
US11896032B2 (en) 2016-05-26 2024-02-13 Tsubakisangyo Co., Ltd. Agent for improving feed conversion rate, agent for improving survival rate, agent for improving the number of eggs laid by egg-laying hen, and method of giving same to animals, and feed
US11173184B2 (en) * 2016-05-31 2021-11-16 Evonik Operations Gmbh Bacillus subtilis strain with probiotic activity
CN106497822A (zh) * 2016-09-23 2017-03-15 天津科技大学 一种南美白对虾饲用微生物制剂及制备和应用方法
CA2959252A1 (en) 2016-10-03 2018-04-03 Bio-Cat, Inc. Bacillus compositions and uses thereof
TW201813514A (zh) * 2016-10-05 2018-04-16 林秀霞 促進豬隻生長及改善養殖環境汙染的製劑和方法
MX2019010805A (es) * 2017-03-14 2019-12-16 Chr Hansen As Cepas de bacillus subtilis que mejoran los parametros de rendimiento animal.
US11446339B2 (en) 2017-03-31 2022-09-20 Pebble Labs Inc. System for the biocontrol of white spot syndrome virus (WSSV) in aquaculture
AU2018243858A1 (en) * 2017-03-31 2019-10-10 Pebble Labs Usa Inc. Novel system for the biocontrol of pathogens in aquaculture and other animal systems
US20200113952A1 (en) * 2017-06-30 2020-04-16 Evonik Operations Gmbh Bacillus subtilis strain with probiotic activity
US11622569B2 (en) 2017-07-24 2023-04-11 Church & Dwight Co., Inc. Bacillus microbial terroir for pathogen control in swine
EP3664616A4 (en) 2017-08-07 2021-08-11 Pebble Labs, Inc. SYSTEMS AND METHODS FOR CONTROLLING ACUTE HEPATOPANCREATIC NECROSIS DISEASE
AR113371A1 (es) * 2017-10-18 2020-04-22 Ascus Biosciences Inc Aumento de la producción de aves de corral mediante la administración de un bioensamblaje sintético de microbios o cepas purificadas de los mismos
JP7416722B2 (ja) * 2018-01-24 2024-01-17 オムニゲン リサーチ エルエルシー 動物への投与のためのバチルス菌の組み合わせ
EP3745876A1 (en) * 2018-02-02 2020-12-09 Novozymes A/S Management of pathogenic lawsonia
EP3764807A4 (en) 2018-03-14 2021-11-03 Sustainable Community Development, LLC PROBIOTIC AND FOOD ADDITIVE COMPOSITION
US20190289878A1 (en) * 2018-03-23 2019-09-26 Purina Animal Nutrition Llc Methods of feeding animals feed products containing direct-fed microbials
WO2019213243A1 (en) * 2018-05-01 2019-11-07 Microbial Discovery Group, Llc Microbials for feed
BR112021005767A2 (pt) 2018-09-28 2021-06-22 Microbial Discovery Group, Llc microrganismos para inibição do patógeno de planta
BR112021005933A2 (pt) * 2018-09-28 2021-06-29 Locus Ip Company, Llc composições e métodos para alimentar animais domesticados
US20200138877A1 (en) * 2018-10-02 2020-05-07 Microbial Discovery Group, Llc Microbials for animals
EP3870690A2 (en) * 2018-10-24 2021-09-01 CIIMAR - Centro Interdisciplinar de Investigação Marinha e Ambiental Sporeforming probiotic strains, methods and uses thereof
CN109287890B (zh) * 2018-11-16 2022-04-19 青岛贝宝海洋科技有限公司 含萌发剂的水产养殖用凝结芽孢杆菌饲料添加剂及其制备方法
AU2020272591A1 (en) 2019-04-12 2021-11-04 Locus Ip Company, Llc Pasture treatments for enhanced carbon sequestration and reduction in livestock-produced greenhouse gas emissions
US11160838B2 (en) 2019-08-09 2021-11-02 Deerland Enzymes, Inc. Antifungal and antimicrobial uses of Bacillus subtilis containing compositions
KR102393430B1 (ko) * 2019-10-18 2022-05-02 (주)에이티바이오 프로바이오틱스를 활용한 사료 및 그 제조방법
CN111607541B (zh) * 2020-06-09 2022-09-16 中国水产科学研究院黑龙江水产研究所 一种虹鳟源枯草芽孢杆菌菌株及其筛选方法和应用
EP4247182A1 (en) * 2020-11-23 2023-09-27 Univerza V Ljubljani Bacillus subtilis strain with strong inhibition of enteropathogenic and foodborne pathogenic bacteria
US20220174984A1 (en) * 2020-12-09 2022-06-09 Purina Animal Nutrition Llc Feed compositions and methods for inhibiting focal ulcerative dermatitis
CN116887690A (zh) * 2020-12-25 2023-10-13 株式会社林原 家畜和/或家禽的生产性改善方法及肠内菌丛改善方法
CN112890014B (zh) * 2021-01-29 2024-01-23 河南科技大学 采用复合益生菌发酵浓香型酒糟生产抗生素代替剂的方法
WO2023220288A1 (en) * 2022-05-12 2023-11-16 Can Technologies, Inc. Feed additive compositions comprising microbial fermentate for the treatment and prevention of pathogen associated disease

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US508080A (en) * 1893-11-07 Autographic register
DE3067173D1 (en) 1979-10-19 1984-04-26 Ici Plc Process for the production of anti-static thermoplastics films and the films thereby produced
JPS62232343A (ja) * 1986-04-01 1987-10-12 Kyodo Shiryo Kk 幼豚用配合飼料
JPS63209580A (ja) * 1987-02-25 1988-08-31 Karupisu Shokuhin Kogyo Kk バチルス・ズブチリスｃ−３１０２
KR930001383B1 (ko) 1990-10-31 1993-02-27 재단법인 한국화학연구소 신규의 바실러스 서브틸리스 아종 및 이로부터 생산되는 항진균 물질 krf-001 복합체의 용도
JPH0754041A (ja) * 1993-08-13 1995-02-28 Sumitomo Metal Ind Ltd 冷間鍛造用鋼の製造方法
US5785990A (en) * 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
JP2979294B2 (ja) * 1996-10-02 1999-11-15 カルピス株式会社 鳥類卵殻強度増強剤
US6103228A (en) * 1997-05-09 2000-08-15 Agraquest, Inc. Compositions and methods for controlling plant pests
PL198772B1 (pl) 1997-05-09 2008-07-31 Agraquest Biologicznie czysta kultura Bacillus subtilis, jej metabolit i supernatant z hodowli szczepu, kompozycje do ochrony roślin i owoców przed szkodnikami, sposób ochrony lub leczenia roślin i owoców, agrastatyny, sposób izolowania supernatantu o aktywności owadobójczej
US6015553A (en) * 1997-08-22 2000-01-18 Agraquest, Inc. Bacillus subtilis strain for controlling insect and nematode pests
JP3260111B2 (ja) * 1997-10-09 2002-02-25 伊藤忠飼料株式会社 鳥類の給餌中止時の体重減少抑制方法及び腸内有害細菌減少方法
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
JP2000166583A (ja) 1998-10-02 2000-06-20 Shin Nihonsha:Kk 枯草菌等が産生する無機物及びその酸塩と副産物及びその誘導体
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
GB0130789D0 (en) 2001-12-21 2002-02-06 King S College London Application of spores
AR040927A1 (es) * 2002-04-10 2005-04-27 Cooperativas Argentinas Cooper Alimento para la crianza de vacunos neonatos y procedimiento de utilizacion.
AT413191B (de) * 2002-10-11 2005-12-15 Erber Ag Futtermittel- und/oder trinkwasserzusatz für nutztiere
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
EP1472933A1 (en) * 2003-05-01 2004-11-03 Chr. Hansen A/S Improving health and/or nutritional status of an aquatic animal by aid of Bacillus licheniformis
US20070065540A1 (en) * 2003-07-24 2007-03-22 Jones Alison M Enhanced steep-water
RU2266747C1 (ru) * 2004-03-22 2005-12-27 Кубанский государственный аграрный университет Пробиотическая композиция для животных и птицы
KR100587447B1 (ko) * 2004-03-24 2006-06-12 한국화학연구원 바실러스 서브틸리스 ｅｂ120 균주, 이를 포함하는 식물병 방제용 미생물 제제 및 이를 이용하여 식물병을 방제하는방법
US20080057047A1 (en) * 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
US7754469B2 (en) 2005-11-30 2010-07-13 Agtech Products, Inc Microorganisms and methods for treating poultry
JP4968816B2 (ja) 2006-03-08 2012-07-04 日本曹達株式会社 バチルス属細菌の芽胞形成方法
WO2007150052A1 (en) 2006-06-23 2007-12-27 Equine Research Associates, Ltd Animal nutritional supplement and method
US9078447B2 (en) 2007-09-20 2015-07-14 Bayer Cropscience Lp Combinations comprising a fungicidal strain and an active compound
CA2736885C (en) 2008-09-17 2016-12-06 Agraquest, Inc. Method for using a bacillus subtilis strain to enhance animal health
US8227235B2 (en) * 2008-12-10 2012-07-24 Alpharma, Llc Compositions and methods for controlling diseases in animals
MY161197A (en) 2010-03-17 2017-04-14 Agraquest Inc Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions

Also Published As

Publication number Publication date
US20100092428A1 (en) 2010-04-15
DK2348880T3 (en) 2015-01-26
RU2011114988A (ru) 2012-10-27
ZA201102627B (en) 2012-06-27
ES2567296T3 (es) 2016-04-21
NZ592154A (en) 2012-12-21
AR073606A1 (es) 2010-11-17
PH12015501581B1 (en) 2015-12-14
EP2754354A1 (en) 2014-07-16
AU2009293213A1 (en) 2010-03-25
CA2736885C (en) 2016-12-06
CO6361864A2 (es) 2012-01-20
CR20110206A (es) 2011-07-06
ECSP11010975A (es) 2011-07-29
EP2754354B1 (en) 2016-01-13
WO2010033714A1 (en) 2010-03-25
AU2009293213B2 (en) 2014-10-23
ES2527673T3 (es) 2015-01-28
US20120321592A1 (en) 2012-12-20
BRPI0918033A8 (pt) 2017-10-03
EP2348880B1 (en) 2014-10-22
JP6106211B2 (ja) 2017-03-29
AU2009293213C1 (en) 2015-04-30
US9247757B2 (en) 2016-02-02
JP2012502920A (ja) 2012-02-02
EP2348880A1 (en) 2011-08-03
MX2011002889A (es) 2011-09-26
EP2348880A4 (en) 2011-11-23
JP2015205896A (ja) 2015-11-19
PE20120074A1 (es) 2012-02-26
PL2348880T3 (pl) 2015-04-30
DK2754354T3 (en) 2016-03-21
CA2736885A1 (en) 2010-03-25
JP6084771B2 (ja) 2017-02-22
BRPI0918033A2 (pt) 2015-10-06
PH12015501581A1 (en) 2015-12-14
CN102223809A (zh) 2011-10-19
TWI574628B (zh) 2017-03-21
CN107047934A (zh) 2017-08-18
RU2544952C2 (ru) 2015-03-20
TW201023759A (en) 2010-07-01
US20160100607A1 (en) 2016-04-14

Similar Documents

Publication Publication Date Title
CL2009001874A1 (es) Uso de bacillus subtilis qst713 nrrl b-21661 para formular una composición probiótica para un animal; y composición probiotica de bacillus subtilis qst713 nrrl b-21661.
ES2524458T3 (es) DNasa para el tratamiento de la subfertilidad masculina
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
CL2011000891A1 (es) Uso de la cepa probiotica lactobacillus reuteri dsm17938 o una composicion nutricional que comprende una cepa bacteriana probiotica lactobacillus reuteri dsm17938 porque sirve para preparar un medicamento o una composicion nutricional util para reducir las alteraciones de sueño y/o mejorar la calidad del sueño o los patrones de sueño en humanos o animales.
MY160041A (en) Compositions and methods for treating parasitic infections
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
MX348797B (es) Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel.
HN2008001720A (es) Arilimidazolonas y ariltriazolonas sustituidas como inihibidores de receptores de vasopresina
MX2009012694A (es) Composicones y metodos utiles para modular la inmunidad, mejorar la eficacia de vacunas, disminuir la morbilidad asociada con infecciones cronicas por fhv-1, y prevenir o tratar la conjuntivitis.
PA8846101A1 (es) Anticuerpos del receptor ii anti-tgf-beta
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
CR10309A (es) "compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1"
ECSP11011459A (es) Composiciones sublinguales de dexmedetomidina y métodos de uso de ellas
CL2012002706A1 (es) Composicion farmaceutica termogelificante estabilizada compuesta por anestesicos locales con un ph de al menos el pka de dichos anestesicos, que comprende a) la forma basica de uno o mas anestesicos de tipo amida, b) 10 a 30% de un aceite de ricino polioxietilado, y c) al menos 15% de uno o mas tensioactivos; y su metodo de preparacion.
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
AR077125A1 (es) Combinaciones farmaceuticas utiles para tratar el vhc
PE20120791A1 (es) Composiciones y metodos para terapia prolongada con aminopiridinas
AR077139A1 (es) Composiciones farmaceuticas utiles para tratar el vch
AR077138A1 (es) Composiciones farmaceuticas utiles para tratar el vhc
MX2012006629A (es) Microorganismos probioticos como agentes activos contra cambios en microrelieve de la piel.
CL2009001328A1 (es) Compuestos derivados de 3-oxo-isoindolin-1-carboxamida, moduladores del canal de sodio nav1,7; composicion farmaceutica que comprende dichos compuestos; y uso en el tratamiento de un trastorno del dolor.
WO2011048554A3 (fr) Association d'un lysat de probiotique et d'un derive c-glycoside
CL2008002758A1 (es) Composicion que comprende al menos un principio activo laxante y al menos un principio activo antiespumante; uso para el tratamiento del estrenimiento.
CL2012003119A1 (es) Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre.